AXSM
Price
$103.36
Change
+$0.79 (+0.77%)
Updated
Jun 27 closing price
Capitalization
5.09B
43 days until earnings call
CRNX
Price
$29.96
Change
-$0.45 (-1.48%)
Updated
Jun 27 closing price
Capitalization
2.81B
40 days until earnings call
Interact to see
Advertisement

AXSM vs CRNX

Header iconAXSM vs CRNX Comparison
Open Charts AXSM vs CRNXBanner chart's image
Axsome Therapeutics
Price$103.36
Change+$0.79 (+0.77%)
Volume$1.18M
Capitalization5.09B
Crinetics Pharmaceuticals
Price$29.96
Change-$0.45 (-1.48%)
Volume$1.64M
Capitalization2.81B
AXSM vs CRNX Comparison Chart in %
Loading...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXSM vs. CRNX commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXSM is a Buy and CRNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (AXSM: $103.36 vs. CRNX: $29.96)
Brand notoriety: AXSM and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXSM: 183% vs. CRNX: 213%
Market capitalization -- AXSM: $5.09B vs. CRNX: $2.81B
AXSM [@Biotechnology] is valued at $5.09B. CRNX’s [@Biotechnology] market capitalization is $2.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXSM’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • AXSM’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both AXSM and CRNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXSM’s TA Score shows that 1 TA indicator(s) are bullish while CRNX’s TA Score has 2 bullish TA indicator(s).

  • AXSM’s TA Score: 1 bullish, 6 bearish.
  • CRNX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than AXSM.

Price Growth

AXSM (@Biotechnology) experienced а +2.65% price change this week, while CRNX (@Biotechnology) price change was -1.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

AXSM is expected to report earnings on Aug 11, 2025.

CRNX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXSM($5.09B) has a higher market cap than CRNX($2.81B). AXSM YTD gains are higher at: 22.160 vs. CRNX (-41.404). AXSM has higher annual earnings (EBITDA): -262.01M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. AXSM (301M). CRNX has less debt than AXSM: CRNX (50.8M) vs AXSM (211M). AXSM has higher revenues than CRNX: AXSM (432M) vs CRNX (760K).
AXSMCRNXAXSM / CRNX
Capitalization5.09B2.81B181%
EBITDA-262.01M-373.49M70%
Gain YTD22.160-41.404-54%
P/E RatioN/AN/A-
Revenue432M760K56,842%
Total Cash301M1.27B24%
Total Debt211M50.8M415%
FUNDAMENTALS RATINGS
AXSM vs CRNX: Fundamental Ratings
AXSM
CRNX
OUTLOOK RATING
1..100
8461
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
6867
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
5264
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRNX's Valuation (92) in the Pharmaceuticals Major industry is in the same range as AXSM (93) in the Pharmaceuticals Other industry. This means that CRNX’s stock grew similarly to AXSM’s over the last 12 months.

CRNX's Profit vs Risk Rating (67) in the Pharmaceuticals Major industry is in the same range as AXSM (68) in the Pharmaceuticals Other industry. This means that CRNX’s stock grew similarly to AXSM’s over the last 12 months.

CRNX's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as AXSM (100) in the Pharmaceuticals Other industry. This means that CRNX’s stock grew similarly to AXSM’s over the last 12 months.

AXSM's Price Growth Rating (52) in the Pharmaceuticals Other industry is in the same range as CRNX (64) in the Pharmaceuticals Major industry. This means that AXSM’s stock grew similarly to CRNX’s over the last 12 months.

AXSM's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that AXSM’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXSMCRNX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 10 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAMRX91.680.74
+0.81%
Janus Henderson Research T
MWOCX49.240.33
+0.67%
MFS Global Growth C
PADEX22.060.10
+0.46%
Putnam Dynamic Asset Allocation Gr R5
BMIDX17.810.08
+0.45%
Brown Advisory Mid-Cap Growth Investor
BRSYX14.290.06
+0.42%
MFS Blended Research Small Cap Eq R6

AXSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with CRNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
+0.77%
CRNX - AXSM
41%
Loosely correlated
-0.10%
ACHV - AXSM
40%
Loosely correlated
-36.47%
PLRX - AXSM
39%
Loosely correlated
-3.08%
XENE - AXSM
37%
Loosely correlated
+0.62%
IONS - AXSM
37%
Loosely correlated
N/A
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-0.10%
XNCR - CRNX
58%
Loosely correlated
-3.10%
TRDA - CRNX
57%
Loosely correlated
-1.57%
DYN - CRNX
56%
Loosely correlated
-4.78%
IDYA - CRNX
55%
Loosely correlated
-4.13%
RVMD - CRNX
55%
Loosely correlated
-1.52%
More